Growth Metrics

Conmed (CNMD) Net Cash Flow Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -53.07%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 17.60%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -562.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -283.58%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -564.44%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 76.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -31.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -394.13%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 57.36%
10 Conmed 1.06 Bn 1.02 Bn 183.45 Mn -148.72%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -148.72%
Dec 31, 2025 115.75%
Sep 30, 2025 -44.44%
Jun 30, 2025 28.54%
Mar 31, 2025 1.34%
Dec 31, 2024 -62.91%
Sep 30, 2024 155.51%
Jun 30, 2024 -421.96%
Mar 31, 2024 466.12%
Dec 31, 2023 -12.89%
Sep 30, 2023 118.95%
Jun 30, 2023 -95.42%
Mar 31, 2023 -166.61%
Dec 31, 2022 37.20%
Sep 30, 2022 -32.02%
Jun 30, 2022 222.06%
Mar 31, 2022 -60.15%
Dec 31, 2021 -0.24%
Sep 30, 2021 -2,238.06%
Jun 30, 2021 -6.40%
Mar 31, 2021 4,875.58%
Dec 31, 2020 -105.12%
Sep 30, 2020 -107.21%
Jun 30, 2020 1,007.39%
Mar 31, 2020 -103.57%
Dec 31, 2019 57.63%
Sep 30, 2019 30.86%
Jun 30, 2019 -132.43%
Mar 31, 2019 150.46%
Dec 31, 2018 -1.50%
Sep 30, 2018 122.66%
Jun 30, 2018 -13.51%
Mar 31, 2018 -286.99%
Dec 31, 2017 -662.20%
Sep 30, 2017 -12.33%
Jun 30, 2017 -12.90%
Mar 31, 2017 112.09%
Dec 31, 2016 -74.53%
Sep 30, 2016 -43.74%
Jun 30, 2016 185.85%
Mar 31, 2016 -1,113.70%
Dec 31, 2015 71.94%
Sep 30, 2015 -31.35%
Jun 30, 2015 -258.46%
Mar 31, 2015 200.11%
Dec 31, 2014 -4.14%
Sep 30, 2014 -20.23%
Jun 30, 2014 -52.08%
Mar 31, 2014 -80.47%
Dec 31, 2013 -16.63%
Sep 30, 2013 148.20%
Jun 30, 2013 381.48%
Mar 31, 2013 226.51%
Dec 31, 2012 143.22%
Sep 30, 2012 -75.41%
Jun 30, 2012 -139.97%
Mar 31, 2012 -248.68%
Dec 31, 2011 -272.64%
Sep 30, 2011 153.89%